<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Maintaining SUV Accuracy in Low-Count PET with PETfectior: A Deep Learning Denoising Solution - Health AI Hub</title>
    <meta name="description" content="This paper presents an initial clinical validation of PETfectior, a deep learning-based denoising software designed to process low-count PET images and maintain">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Maintaining SUV Accuracy in Low-Count PET with PETfectior: A Deep Learning Denoising Solution</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.02917v1" target="_blank">2512.02917v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-02
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yamila Rotstein Habarnau, Nicol√°s Bustos, Paola Corona, Christian Gonz√°lez, Sonia Traverso, Federico Matorra, Francisco Funes, Juan Mart√≠n Giraut, Laura Pelegrina, Gabriel Bruno, Mauro Nam√≠as
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> eess.IV, physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.02917v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.02917v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents an initial clinical validation of PETfectior, a deep learning-based denoising software designed to process low-count PET images and maintain SUV accuracy. The study demonstrates that PETfectior can generate high-quality diagnostic images from scans acquired with half the standard counting statistics, achieving excellent lesion detectability, accurate quantitative performance, and superior subjective image quality.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medical practice as it offers a solution to significantly reduce patient radiation exposure and healthcare costs associated with PET/CT imaging. By maintaining diagnostic accuracy and image quality with lower activity doses or shorter scan times, it enhances patient safety and potentially increases the accessibility of critical oncological imaging.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>PETfectior is an AI-based (specifically deep learning) software designed to process low-count PET scans to increase their signal-to-noise ratio and produce high-quality images. This allows for accurate diagnosis and quantification (SUVmax) of oncologic lesions using half the standard radiation dose and radiopharmaceutical amount, directly improving patient safety and reducing healthcare costs in medical imaging diagnostics.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>PETfectior is an artificial intelligence-based software engineered to increase the signal-to-noise ratio in low-count PET images, enabling high-quality results from reduced acquisition times or administered activities.</li>
                    
                    <li>The study prospectively included 258 patients undergoing 18F-FDG PET/CT, comparing standard-of-care scans (100% counting statistics) with PETfectior-processed scans generated from half-counting statistics (50%+PETfectior).</li>
                    
                    <li>The 50%+PETfectior images exhibited high sensitivity for lesion detection (99.9%) among 1649 identified oncologic lesions, with only one false positive detected.</li>
                    
                    <li>Quantitative analysis showed strong agreement in SUVmax measurements between 100% and 50%+PETfectior images, with a mean bias of -1.01% and 95% limits of agreement within 12.5%.</li>
                    
                    <li>Subjective image quality of the 50%+PETfectior images was rated by experienced physicians as equal to or better than the standard full-count images.</li>
                    
                    <li>This approach aligns with EANM quantitative standards while significantly reducing patient radiation exposure and radiopharmaceutical costs.</li>
                    
                    <li>The findings support the safe clinical implementation of PETfectior, allowing for diagnostic quality PET scans with reduced counting statistics without compromising accuracy or image quality.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>A prospective clinical validation study was conducted on 258 patients undergoing 18F-FDG PET/CT. Standard-of-care scans (100% counting statistics) were acquired and reconstructed per EARL standards 2. Half-counting-statistics versions (50%+PETfectior) were generated from list-mode data and processed using PETfectior. Oncologic lesions were segmented, and evaluation included lesion detectability (sensitivity, false positives), quantitative performance of SUVmax (concordance, bias, 95% limits of agreement), and subjective image quality assessed by two experienced physicians.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Across 198 studies and 1649 lesions, 50%+PETfectior images achieved 99.9% sensitivity for lesion detection with only 1 false positive. SUVmax measurements between 100% and 50%+PETfectior images showed a low bias of -1.01% and agreed within 12.5% (95% limits of agreement). Subjective image quality of the PETfectior-processed low-count images was consistently rated as equal to or superior to the standard full-count images.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>PETfectior can fundamentally alter current PET imaging protocols by enabling accurate and high-quality diagnostics with half the standard radiopharmaceutical dose or acquisition time. This directly translates to reduced radiation burden for patients, lower operational costs for healthcare providers, and potentially shorter patient throughput times, making PET scans safer, more efficient, and more cost-effective in oncology.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract specifies this as an 'initial clinical validation,' implying that further broader studies are warranted. While sensitivity for lesion detection is high, the overall specificity is not explicitly detailed beyond the single false positive. The generalizability across different PET scanner models or diverse patient populations and disease types is also not elaborated.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Although not explicitly stated in the abstract, the 'initial clinical validation' implies a need for further expanded validation across different patient cohorts, various cancer types, and multiple PET scanner platforms. Future research could also investigate the long-term impact on clinical decision-making and patient outcomes, and potentially explore applicability to other PET radiotracers.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Nuclear Medicine</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Radiology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">PET</span>
                    
                    <span class="tag tag-keyword">SUVmax</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Denoising</span>
                    
                    <span class="tag tag-keyword">Low-Count PET</span>
                    
                    <span class="tag tag-keyword">18F-FDG</span>
                    
                    <span class="tag tag-keyword">Oncology</span>
                    
                    <span class="tag tag-keyword">Radiopharmaceutical Cost</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Background: Diagnostic PET image quality depends on the administered activity and acquisition time. However, minimizing these variables is desirable to reduce patient radiation exposure and radiopharmaceutical costs. PETfectior is an artificial intelligence-based software that processes PET scans and increases signal-to-noise ratio, obtaining high-quality images from low-count-rate images. We perform an initial clinical validation of PETfectior on images acquired with half of the counting statistics required to meet the most recent EANM quantitative standards for 18F-FDG PET, evaluating lesions detectability, quantitative performance and image quality.
  Materials and methods: 258 patients referred for 18F-FDG PET/CT were prospectively included. The standard-of-care scans (100% scans) were acquired and reconstructed according to EARL standards 2. Half-counting-statistics versions were generated from list-mode data and processed with PETfecftior (50%+PETfectior scans). All oncologic lesions were segmented on both PET/CT versions, manually or automatically, and lesions detectability was evaluated. The SUVmax of the lesions was measured and the quantitative concordance of 50%+PETfectior and 100% images was evaluated. Subjective image quality was visually assessed by two experienced physicians.
  Results: 1649 lesions were detected in a total of 198 studies. The 50%+PETfectior images showed high sensitivity for lesion detection (99.9%) and only 1 false positive was detected. The SUVmax measured in 100% and 50%+PETfectior images agreed within 12.5% (95% limits of agreement), with a bias of -1.01%. Image quality of the 50%+PETfectior images was rated equal to or better than the standard-of-care images.
  Conclusion: PETfectior can safely be used in clinical practice at half counting statistics, with high sensitivity and specificity, low quantitative bias and high subjective image quality.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>